Scaling Microcarrier-based Expansion Processes for Production of High Quality Cells

Similar documents
Application Note USD 3086 (1) Animal Component-Free Star-Plus Microcarriers for Adherent Mammalian Cell Culture

Application Note USD3084. Allegro Microcarrier Delivery System (AMDS)

Results and Discussion

Application Note USD 2975 (1) Pall SoloHill Microcarriers in the PadReactor Single-Use Bioreactor

Mesenchymal stem cells

Rachel Legmann, PhD ISCT, October 2, 2016 Memphis, TN

BD MOSAIC h MSC CELL CULTURE ENVIRONMENT DEFINED SERUM FREE

Efficient Expansion of Human Mesenchymal Stem Cells (hmscs) on Corning Enhanced Attachment Microcarriers Using a Continuous Agitation Protocol

Pros and cons of different expansion systems for manufacturing of an allogeneic cell therapy

Application Note USD Microcarrier Mixing in PadReactor Mini Bioreactor

Expansion of Human Mesenchymal Stem Cells Using Corning HYPER Technology Cell Culture Vessels

Regenerative Medicine and Stem Cell Therapies

PRIME-XV Cell Therapy Products by

Cell Characterization: Developing Assays to Address the Biological Parameters of Identity and Potency

PRIME-XV Cell Therapy Products by

Optimizing the HyPerforma Single-Use Bioreactor for adherent cell culture on microcarriers

Optimizing the HyPerforma Single-Use Bioreactor for adherent cell culture on microcarriers

Expansion of Human Mesenchymal Stem Cells Using Corning HYPER Technology Cell Culture Vessels

Culture of human mesenchymal stem cells in Nunc Cell Factory systems

Mesenchymal Stromal Cells Large-scale Culture

Parameters to Consider When Expanding Cells on Corning Microcarriers

Current Considerations on Chemistry, Manufacturing and Control of Cell Therapy Products (CTPs)

Outcomes in Mesenchymal Stem Cell Manufacturing. Athena Russell, MT(AAB) Human Cellular Therapy Laboratory Mayo Clinic Jacksonville, FL

Cellartis MSC Xeno-Free Culture Medium

Large-scale production of human mesenchymal stem cells for clinical applications

Application Note USD 2974 (2) Expansion of Vero Cells on Hillex II Microcarriers via Serial Passage in Stirred Vessels

Allen Chen, Yu Ming Lim, Shaul Reuveny and Steve Oh

Challenges in the cgmp Manufacturing of hescs: Lessons Learned from Monoclonal Antibodies

Mesenchymal Stem Cells

Stem Cells, Regenerative Medicine and cgmp (GTP)

BalanCD HEK293 SYSTEM

Welcome to the Spring 2017 Newsletter for the EU Project AUTOSTEM

BalanCD HEK293 SYSTEM

Stem cell transfection guide

Application Note. Introduction. Kerry Thompson, Jeff Partridge, Paula Flaherty, Susan Qian, and Deepa Saxena

Devices and Manufacturing Equipment Used for Production of Immune Cell Therapy and Cell Expansion: Scientific/User Issues

SCM Lifescience COMPANY PROFILE BUSINESS AREAS. [Address] 310, 366 Seohae-daero, Jung-gu, Incheon, Korea [Website]

Amsterdam, the Netherlands 29 March 2018

All quality control test results are reported on a lot specific Certificate of Analysis which is available at or upon request.

Regulatory Perspectives of Japan

Improved conventional practices of the pharma industry serving Cost of Goods of Autologous Cell Therapy

A Novel Method for the Expansion of Mesenchymal Stem Cells using a New Brunswick S41i CO 2

All quality control test results are reported on a lot specific Certificate of Analysis which is available at or upon request.

Cortical Neural Induction Kit. Protocol version 1.0

Harvesting Technology Guide for mab Processes. Accelerated process development through the identification of optimal platform solutions

Genome Edited ipscs APOE -/- Knockout

Stem cells for therapeutic use

Mammalian Expression Platform

Case Study: Examples Relating to the Quality Control of Cell-based Products

Use of the XCell ATF in the Manufacture of Suspension Lentiviral Vector

Application Note USD Pall SoloHill Animal Protein-Free Microcarriers for Dengue Virus Production

Cell and gene therapy: scaling up and moving to mass production

Getting to the Factory of the Future

Human Skeletal Muscle Progenitor Cells. Protocol version 2.0

BD Resurge Media Supplements Chemically Defined. Protein Free. Animal Free.

Application of Disposable Technologies in Biopharmaceutical Manufacturing

NEW! CHOgro Expression System

Stem Cells and Cell Culture Developments Within ThermoFisher Scientific

APPROACHES TO IMPROVING THE PERFORMANCE OF MAMMALIAN CELL CULTURES FOR PROTEIN PRODUCTION

Cambrex Cell Therapy. Buckingham Research Conference Call

Human Mesenchymal Stem Cell Growth on Corning Denatured Collagen Dissolvable Microcarriers in a 5L Bioreactor

Validation of Cytodex Gamma microcarrier-based virus production in single-use bioreactor systems

REMEDiE Project London 7-8 May 2009 European Policies and Priorities for Stem Cell Research

Longevity Leaders Conference. February 4, 2019

The NYSCF Research Institute

Serum-Free, Xeno-Free Differentiation Media. for Human Mesenchymal Stem Cells

A Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody.

Editorial Manufacturing Cells for Clinical Use

Critically Evaluating the Benefits of Automation in Commercial- Scale Manufacture

BioWhittaker Specialty Media Maximize Your Cell Growth and Productivity

Scale-Up Solutions for Cell Therapy and. Bioprocess

Cell-based therapies in tissue engineering and regenerative medicine (TE/RM)

Andrew Finnerty General Manager - CCMI

Advancing Manufacturing for Advanced Therapies

Cell-based therapies hold

CONFERENCE EXCLUSIVE. Innovative Disposable Bioreactors For Membrane Protein Production Based on the Tide Principle

Human Bone Marrow Derived Mesenchymal Stem Cell (MSC) Care Manual

Human Skeletal Muscle Cells. Protocol version 2.0


STEMdiff Mesenchymal Progenitor Kit

Lineage-specific Reporter Knock-in ipscs: MAP2-Nanoluc-Halotag ipsc (Heterozygous)

Application Note USD3011. Influenza Virus Production with Adherent VERO Cells in PadReactor Mini Bioreactor

Lineage-specific Reporter Knock-in ipscs: MAP2-Nanoluc-Halotag ipsc (Heterozygous)

Realizing the Future that Regenerative Medicine Will Open

Mixing theory for culture and harvest in bioreactors of human mesenchymal stem cells on microcarriers

Protocol Using the Reprogramming Ecotropic Retrovirus Set: Mouse OSKM to Reprogram MEFs into ips Cells

FectoCHO Expression system DNA transfection kit for protein production PROTOCOL

Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions

Whitepaper. Small Molecule Vs Cell Therapy Clinical Trial Supply Chain. Martin Lamb, Executive Vice President for Sales and Marketing

PMDA s Efforts - Regulation and Innovation. Takao YAMORI, Ph.D. Executive Director Pharmaceuticals and Medical Devices Agency (PMDA)

CHOgro Expression System

Medicyte GmbH. Infinity Gets Cultured. European Business Development Conference, Dresden October 2014 Björn F. Lindemann, CEO

Scaling Down Bioreactor Process Development: Comparison of Microbioreactor and Bench Scale Solutions.

Regulatory requirements for early stage clinical trials with cell-based medicinal products. Christopher A Bravery

Regulatory frameworks of regenerative medicines and products review in Japan

Take the Rational Approach of the BalanCD CHO Media Platform

ABOUT GLYCOSTEM. Company Overview

ISCT Telegraft Column: Mesenchymal Stromal Cell (MSC) Product Characterization and Potency Assay Development

Thermo Scientific Metabolic Pathway Design Process Cell culture media and process optimization approaches for optimal biotherapeutic production

Protocol for Small-Scale Microcarrier Culture

Transcription:

Scaling Microcarrier-based Expansion Processes for Production of High Quality Cells Mark S. Szczypka BioTech 2016, Wädenswil Switzerland September 5 th 2016 This presentation is the work product of Pall Corporation and no portion of this presentation may be copied, published, performed, or redistributed without the express written authority of a Pall corporate officer. 2016 Pall Corporation.

Cell-based Medical Technologies Cell Therapies Allogeneic donor into patient Autologous Cell Therapy patient into same patient Regenerative Medicine Engineered tissues 3D Bio-printing Gene Delivery Drug Discovery and Testing Gene Delivery Live cells for pharmaceutical research Cell Therapies Adult stem cells Primary cells ipsc ES cells Regenerative Medicine Drug Discovery 2

Cell Numbers for Therapeutic Applications and Enabling Technology Allogeneic cell therapy Indication Patients/year Cells/year (TD 1e 9 ) (Global) (Global) Ischemic Stroke 2.00E+06 2.00E+15 Acute Myocardial Infarction 4.00E+06 Regenerative Medicine Indication Islets for Type I diabetes 4.00E+15 Stem Cells/patient 1B TH positive neurons for Parkinson s 2 T Xpansion 2D cell culture reactors 3 Pad Bioreactors

Building a Simple and Robust Cell Manufacturing Platform for Scalable Expansion of hmsc Critical components Donor tissue and methods used for isolation Cells and Medium Expansion platform Substrate for attachment Bioreactor type Ancillary technologies and processes Standardized sterile connections Holding and process containers Volume reduction methods Storage containers 4

Pall SoloHill Microcarriers for Cell Expansion Six Different highly characterized microcarrier types Used in large scale manufacturing processes for over 30 years Rigid cores allow for easy and rapid dissociation and high cell yields Support robust growth of many different types of human and animal cells Excellent performance in serial passage Gamma-irradiated microcarriers in single-use bags facilitate ease of use Best overall performance in independent studies for microcarrier selection* * Rafiq et al. Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactor Biotech J. 2016. 5

Robust Growth of hmscs on Pall SoloHill Microcarriers Cells/mL (x 10 6 ) 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0.0 Bioreactor Culture Spinner Control 0 2 4 6 8 Days of Growth Medium Exchange Cells/cm 2 (x 10 4 ) 10.0 9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 0 2 3 4 5 6 7 Days of Growth Bioreactor Harvest Collagen Star-Plus 1 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 Cells/mL (x 10 6 ) Collagen Star-Plus Medium Exchange 2.4 B 1.3 B Excellent growth and efficient harvest of human mesenchymal stem cells (hmscs) from Pall SoloHill microcarriers in small scale bioreactors 6

Robust Growth of hmscs on Pall SoloHill Collagen Coated Microcarriers Adipocyte Osteocyte % Gated Cells 100 80 60 Collagen Bioreactor Bioreactor T Flask Control 40 20 0 Marker hmsc harvested from microcarriers retain differentiation capacity and surface marker expression 7

hmsc Expansion using PadReactor Platform and Pall SoloHill Microcarriers Allegro Microcarrier Delivery System (AMDS-Irradiated microcarriers) RoosterBio hmsc (liquid nitrogen stock) 6L PadMini Bioreactor Pad50 3 days 4 days Maintain PDL below 18 to 20 doublings to maintain quality and consistency 8

Adherent Cell Culture Solutions Microcarrier Cell Culture Low shear mixing supports cell growth on microcarriers Superior gas transfer and ph control Linear scalable bioreactors (6L to 1000L) Downscale bioreactors for PD and small scale GMP batches 9 SoloHill microcarriers, delivered ready-to-use in a single use format Sterilized by gamma irradiation Allows to directly seed bioreactors no additional preparation needed

RoosterBio hmsc and Medium Process parameters: 1. Cell thawed & seeded at 10,000 cells/ml or 5M per 500ml culture 2. collagen coated microcarriers 3. Media Feed added on day 3 40-fold increase in viable cell number over 1 week RoosterBio media feed (RoosterReplenish) can be used to replace media exchange during bioreactor culture Efficient hmsc detachment from microcarriers (Data generated by RoosterBio) 10

Small scale microcarrier passage studies P1 microcarriers Harvest P2 microcarriers 0.6 Passage 2 Cells/mL (x 10 6 ) 0.5 0.4 0.3 0.2 0.1 Microcarrier (n=1) Planar culture 0.0 Day 5 11

Reproducible and Robust Cell Expansion in 6 Liter PadMini Bioreactor 0.60 Expansion Scheme Cells/mL (x 10 6 ) 0.50 0.40 0.30 0.20 0.10 BR (n = 3) CF10 LN 2 Cell Factory (CF10) Bioreactor Process Parameters PadMini (6L) RoosterBio hmsc RoosterBio High Performance media Seed density 3000 cells/cm 2 0.00 Day 4 Microcarrier conc. Medium exchange 10 cm 2 /ml None Supplement Day 3 Over twenty-fold expansion was reproducibly achieved in batch-fed microcarrier cultures in PadMini at 6L scale in 4 days 12

Generation of Billons of hmsc in Pall s Single use PadReactors in 8 days Total cells 3 days 5 days Pad Mini (6 L) Pad 50 (40L) Seed Harvest Seed Harvest 1.67E+08 1.23E+09 1.11E+09 2.79E+10 PDL 2.9 4.6 Cell Expansion 0.17 B 28 B Cells/mL (x 10 6 ) 1.2 1 0.8 0.6 0.4 0.2 0 PAD50 Reactor 0 2 4 6 Day 13

Conclusions PadReactors used in a closed system provide an ideal singleuse bioreactor system for cell expansion Pall SoloHill microcarriers provided an excellent substrate for growth of human mesenchymal stem cells (hmsc). Cells were harvested from microcarriers using simple procedures Simplification of processes steps including use of Sterile microcarriers delivered through the AMDS in single-use bioreactors hmsc were expanded from ~170 million hmsc to 28 billion cells in 8 days in batch-fed culture on SoloHill microcarriers in Padreactors 14

Expansion using PadReactor Platform and Pall SoloHill Microcarriers Expedite developmental timelines for cell-based Medical technologies Provide robustness and reproducibility in single-use closed system Decrease cost of implementation hmsc 6L PadMini Bioreactor Pad50 15

Acknowledgements Pall Life Sciences Dave Splan RoosterBio (Cells and Media) Lye-Theng Lock Jon Rowley Jin Liu Alexandria Spruiel Kaitlynn Bayne Grishma Patel Andrew Laskowski 16

Thank You